Nuevos horizontes en la investigación del cáncer: del laboratorio al paciente CNIO Workshop on Philosophy & Biomedical Sciences: Debates on conceptual and social issues Heterogeneity and evolution in cancer

Inicio | Eventos | Computational Drug Discovery: from Structure-Based Design to Artificial Intelligence and Beyond

Computational Drug Discovery: from Structure-Based Design to Artificial Intelligence and Beyond

Información

Fecha: 08/05/2019
Hora 11:00
Lugar: 3rd floor seminar room
Conferenciante Alvaro Cortes
Procedencia Head of Computational Chemistry and Biology. Galchimia S.A. for GlaxoSmithKline (GSK), Madrid, Spain
Invitado por Oscar Llorca, Director Structural Biology Programme

Subir